HGS Shares Rise After Stock Split Approved | GenomeWeb

NEW YORK, Sept 19 - Human Genome Sciences (Nasdaq: HGSI) stock jumped 9 13/16, or 6.8 percent, to 153 13/16 in mid-morning trading Tuesday following an announcement on  Monday after the close of trading that the company’s board had approved a two-for-one stock split.

Shareholders will receive an additional common share for each share held at close-of-business on Sept. 28. The additional shares will be delivered on or about Oct. 5.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.